Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Stock Analysis

Accent Group (ASX:AX1): Can a Retail Reset Create the Next Phase of Growth?

Accent Group (ASX:AX1) is one of Australia and New Zealand’s major footwear and lifestyle retailers, operating multiple retail banners and distributing international footwear and lifestyle brands. The company’s scale provides exposure to consumer spending trends while itsBrandportfolio allows flexibility in adjusting to changing market …

Aditi Sarkar | 02 September 2026

Austin Engineering (ASX:ANG): Can Operational Recovery and Mining Demand Reignite Growth?

Austin Engineering (ASX:ANG) designs and manufactures specialised mining equipment, including dump-truck bodies, trays, buckets and attachments used in large surface-mining operations. The company’s performance is closely linked to mining capital expenditure, replacement cycles and the operating requirements of major resource producers.

Aditi Sarkar | 02 September 2026

Kinatico (ASX:KYP): Can a SaaS Transformation Unlock the Next Phase of Growth?

Kinatico (ASX:KYP) provides workforce compliance and screening technology designed to help organisations manage employee verification, credential checks and ongoing compliance requirements. Its platform supports businesses seeking more efficient ways to manage regulatory obligations around their workforce.

Aditi Sarkar | 02 September 2026

SEEK (ASX:SEK): Can Strong Marketplace Earnings Outweigh Investment Portfolio Challenges?

SEEK (ASX:SEK) operates one of Australia and New Zealand’s leading online employment marketplaces, connecting employers andJobseekers while maintaining exposure to selected international markets. The company’s marketplace position, pricing capability and high-margin operating model have supported long-term growth.

Aditi Sarkar | 02 September 2026

Autosports Group (ASX:ASG): Can Luxury Vehicle Demand Support the Next Phase of Growth?

Autosports Group (ASX:ASG) operates a network of prestige and luxury vehicle dealerships across Australia, with operations spanning vehicle sales, servicing, parts and finance. The company provides exposure to the higher end of the automotive market, where customer demand can differ from broader consumer spending …

Aditi Sarkar | 02 September 2026

IperionX (ASX:IPX): Could This Titanium Technology Stock Surprise Investors?

IperionX (ASX:IPX) is developing a low-carbon titanium supply chain in the United States, using proprietary technologies to produce titanium powder and components from recycled feedstock. Titanium is an important material used across defence, aerospace and advanced manufacturing industries.

Aditi Sarkar | 02 September 2026

Nido Education (ASX:NDO): Is a Fresh Re-Rating Story Starting to Build?

Nido Education (ASX:NDO) operates and manages early-learning and childcare centres across Australia, with a portfolio comprising both owned and managed services. The company operates within a sector supported by structuralDemandand government childcare support, while also facing increased scrutiny around safety, quality and regulatory standards.

Aditi Sarkar | 02 September 2026

Imugene (ASX:IMU): Could the Next Clinical or Commercial Catalyst Spark a Major Re-Rating?

Imugene (ASX:IMU) is a clinical-stage immuno-oncology company developing therapies designed to use the immune system to fight cancer. Its lead program, azer-cel, is focused on allogeneic or “off-the-shelf” CAR-T cell therapy, an approach aimed at addressing some of the limitations associated with patient-specific cell …

Aditi Sarkar | 02 September 2026

SomnoMed (ASX:SOM): Why This Healthcare Stock Remains in Focus After Improving Margins and New Product Launch

SomnoMed (ASX:SOM) develops custom oral appliances for obstructive sleep apnoea, providing dental-style devices designed to help keep airways open during sleep. The company operates within the global sleep-disorder market, offering an alternative treatment option for patients who may not prefer traditional therapies.

Aditi Sarkar | 02 September 2026

Biome Australia (ASX:BIO): Can Probiotic Growth Translate Into a Longer-Term Healthcare Opportunity?

Biome Australia (ASX:BIO) operates in the growing consumer healthcare sector, developing evidence-based probiotics and complementary medicines focused on gut health and microbiome support. Its product portfolio includes the Activated Probiotics range and Biome Daily, which are distributed primarily through pharmacy channels.

Aditi Sarkar | 02 September 2026
Support

Hi! How can we help you today?

Loading…